Vol 60, No 1 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28
Get Citation

Percutaneous balloon aortic valvuloplasty in children: early and long-term outcome

Jacek Kusa, Jacek Białkowski, Małgorzata Szkutnik
Kardiol Pol 2004;60(1):53-56.
Vol 60, No 1 (2004)
Other
Published online: 2005-12-12
Submitted: 2012-12-28

Abstract

Background: A significant aortic stenosis in children causes hypertrophy and destructive changes of the left ventricle (LV). Definitive treatment of this condition consists of aortic valve replacement. Temporary decompression of LV may be achieved by surgical valvulotomy or percutaneous balloon valvuloplasty (PBV). The use of the latter method remains controversial.
Aim: To assess early and long-term effects of PBV of aortic stenosis in children.
Methods: The study group consisted of consecutive 47 patients (age 4 months - 19 years, mean 8.3 years) with congenital aortic stenosis who were selected for PBV performed in a single centre.
Results: PBV was performed in 46 patients and caused significant reduction of the trans-valvular pressure gradient (from 81.4&#177;21.08 mmHg at baseline to 30.5&#177;17.87 mmHg after PBV, p<0.0001). There were no peri-procedural deaths. One local complication occurred - damage of the femoral artery, which was treated surgically. In this patient PBV was not performed. In four patients the procedure was regarded as ineffective. During the mean follow-up of 38.4 (2-108) months there were no deaths, and eight patients underwent various types of cardiac surgery, mainly due to the progression of aortic regurgitation or lack of effects of PBV.
Conclusions: PBV is an effective palliative method for the treatment of congenital aortic stenosis. This procedure enables the delay of surgery till adulthood. Aortic regurgitation is the most common complication, and sometimes requires early surgical intervention.

Abstract

Background: A significant aortic stenosis in children causes hypertrophy and destructive changes of the left ventricle (LV). Definitive treatment of this condition consists of aortic valve replacement. Temporary decompression of LV may be achieved by surgical valvulotomy or percutaneous balloon valvuloplasty (PBV). The use of the latter method remains controversial.
Aim: To assess early and long-term effects of PBV of aortic stenosis in children.
Methods: The study group consisted of consecutive 47 patients (age 4 months - 19 years, mean 8.3 years) with congenital aortic stenosis who were selected for PBV performed in a single centre.
Results: PBV was performed in 46 patients and caused significant reduction of the trans-valvular pressure gradient (from 81.4&#177;21.08 mmHg at baseline to 30.5&#177;17.87 mmHg after PBV, p<0.0001). There were no peri-procedural deaths. One local complication occurred - damage of the femoral artery, which was treated surgically. In this patient PBV was not performed. In four patients the procedure was regarded as ineffective. During the mean follow-up of 38.4 (2-108) months there were no deaths, and eight patients underwent various types of cardiac surgery, mainly due to the progression of aortic regurgitation or lack of effects of PBV.
Conclusions: PBV is an effective palliative method for the treatment of congenital aortic stenosis. This procedure enables the delay of surgery till adulthood. Aortic regurgitation is the most common complication, and sometimes requires early surgical intervention.
Get Citation

Keywords

aortic stenosis - percutaneous balloon valvuloplasty

About this article
Title

Percutaneous balloon aortic valvuloplasty in children: early and long-term outcome

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 60, No 1 (2004)

Pages

53-56

Published online

2005-12-12

Bibliographic record

Kardiol Pol 2004;60(1):53-56.

Keywords

aortic stenosis - percutaneous balloon valvuloplasty

Authors

Jacek Kusa
Jacek Białkowski
Małgorzata Szkutnik

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl